Canntab Therapeutics Ltd (CTABF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Canntab Therapeutics Max Drawdown (5Y): 99.87% for Aug. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
August 31, 2024 | 99.87% |
July 31, 2024 | 99.87% |
June 30, 2024 | 99.87% |
May 31, 2024 | 99.87% |
April 30, 2024 | 99.87% |
March 31, 2024 | 99.87% |
February 29, 2024 | 99.87% |
January 31, 2024 | 99.87% |
December 31, 2023 | 99.87% |
November 30, 2023 | 99.87% |
October 31, 2023 | 99.87% |
September 30, 2023 | 99.87% |
August 31, 2023 | 99.87% |
July 31, 2023 | 99.87% |
June 30, 2023 | 99.87% |
May 31, 2023 | 99.87% |
April 30, 2023 | 99.87% |
March 31, 2023 | 99.87% |
February 28, 2023 | 99.87% |
January 31, 2023 | 99.87% |
December 31, 2022 | 99.87% |
November 30, 2022 | 99.87% |
October 31, 2022 | 99.65% |
September 30, 2022 | 99.31% |
August 31, 2022 | 98.90% |
Date | Value |
---|---|
July 31, 2022 | 98.90% |
June 30, 2022 | 98.54% |
May 31, 2022 | 98.54% |
April 30, 2022 | 98.45% |
March 31, 2022 | 98.45% |
February 28, 2022 | 98.45% |
January 31, 2022 | 98.45% |
December 31, 2021 | 98.45% |
November 30, 2021 | 98.45% |
October 31, 2021 | 98.45% |
September 30, 2021 | 98.45% |
August 31, 2021 | 98.45% |
July 31, 2021 | 98.45% |
June 30, 2021 | 98.45% |
May 31, 2021 | 98.45% |
April 30, 2021 | 98.45% |
March 31, 2021 | 98.45% |
February 28, 2021 | 98.45% |
January 31, 2021 | 98.45% |
December 31, 2020 | 98.45% |
November 30, 2020 | 98.45% |
October 31, 2020 | 98.45% |
September 30, 2020 | 98.45% |
August 31, 2020 | 98.45% |
July 31, 2020 | 98.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.45%
Minimum
Sep 2019
99.87%
Maximum
Nov 2022
98.94%
Average
98.45%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Biosyntech Inc | 100.00% |
Cotinga Pharmaceuticals Inc | 100.00% |
Choom Holdings Inc | 100.00% |
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |